 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/19/2021 |
$116.67 |
$117.00 |
$113.74 |
$115.42 |
6.76M | | 07/20/2021 |
$115.55 |
$117.73 |
$115.46 |
$116.05 |
5.58M | | 07/21/2021 |
$116.64 |
$117.07 |
$115.79 |
$116.99 |
4.13M | | 07/22/2021 |
$116.64 |
$117.91 |
$116.39 |
$117.54 |
6.26M | | 07/23/2021 |
$117.98 |
$118.67 |
$117.57 |
$118.19 |
4.41M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on July 19, 2021, ABBV opened at $116.67, traded as high as $117.00 and as low as $113.74, and closed at $115.42. Trading volume was a total of 6.76M shares. On July 20, 2021, ABBV opened at $115.55, traded as high as $117.73 and as low as $115.46, and closed at $116.05. Trading volume was a total of 5.58M shares. On July 21, 2021, ABBV opened at $116.64, traded as high as $117.07 and as low as $115.79, and closed at $116.99. Trading volume was a total of 4.13M shares. On July 22, 2021, ABBV opened at $116.64, traded as high as $117.91 and as low as $116.39, and closed at $117.54. Trading volume was a total of 6.26M shares. On July 23, 2021, ABBV opened at $117.98, traded as high as $118.67 and as low as $117.57, and closed at $118.19. Trading volume was a total of 4.41M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
07/23/2021 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$118.19 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
408.01 |
|
| Dividends reinvested/share: |
$26.61 |
|
| Total return: |
382.22% |
|
| Average Annual Total Return: |
20.19% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$48,235.48 |
|
| Years: |
8.56 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
07/23/2021 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$118.19 |
|
| Dividends collected/share: |
$26.61 |
|
| Total return: |
312.30% |
|
| Average Annual Total Return: |
18.01% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$41,242.90 |
|
| Years: |
8.56 |
|
|
|
| Date |
Close |
| 07/19/2021 | $115.42 | | 07/20/2021 | $116.05 | | 07/21/2021 | $116.99 | | 07/22/2021 | $117.54 | | 07/23/2021 | $118.19 |
|
|
